A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder

Chester Kao, Megan McNamara, Chris Alley, Neil Spector, Shekeab Jauhari, Rajan T. Gupta, Tian Zhang, Jason Zhu

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)e672-e677
JournalClinical Genitourinary Cancer
Volume17
Issue number3
DOIs
StatePublished - Jun 2019
Externally publishedYes

Keywords

  • Bladder cancer
  • Cisplatin ineligible
  • Immune checkpoint inhibitors
  • Metastatic bladder squamous cell carcinoma
  • PD-1 inhibitor
  • Psuedoprogression

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this